Analyst Price Targets — NSPR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 5, 2026 10:51 am | Adam Maeder | Piper Sandler | $3.00 | $1.17 | TheFly | InspireMD price target lowered to $3 from $4 at Piper Sandler |
| May 4, 2026 12:51 pm | — | Lake Street | $4.00 | $1.18 | TheFly | InspireMD price target lowered to $4 from $5 at Lake Street |
| February 24, 2026 1:55 pm | Frank Takkinen | Loop Capital Markets | $5.00 | $1.82 | StreetInsider | Lake Street Capital Markets Reiterates Buy Rating on InspireMD (NSPR) |
| February 2, 2026 12:44 pm | — | Maxim Group | $6.00 | $1.68 | TheFly | InspireMD initiated with a Buy at Maxim |
| December 11, 2024 1:48 pm | Frank Takkinen | Lake Street | $5.00 | $3.17 | TheFly | InspireMD initiated with a Buy at Lake Street |
| September 17, 2024 7:17 am | Adam Maeder | Piper Sandler | $4.50 | $2.61 | StreetInsider | Piper Sandler Reiterates Overweight Rating on InspireMD (NSPR) |
Latest News for NSPR
- Amendments align trigger event of existing warrants with anticipated FDA approval of CGuard Prime 80 cm, which the Company continues to anticipate in Q4 2026 -
MIAMI, Sept. 04, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of InspireMD's Board of Directors approved inducement grants to a new non-executive employee in the aggregate amount of 23,764 shares of restricted stock (the “Inducement Grants”)…
MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C.
InspireMD (NSPR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
InspireMD, Inc. (NSPR) Q2 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NSPR.
U.S. House Trading
No House trades found for NSPR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.